GI
SANA icon

GAMMA Investing’s Sana Biotechnology SANA Stock Holding History

GAMMA Investing’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-222
Closed -$639 – 4215
2026
Q1 		$639 Sell
222
-33
-13% -$130 ﹤0.01% 3913
2025
Q4 		$1.04K Buy
+255
New +$1.14K ﹤0.01% 3780
2024
Q4 		– Sell
-88
Closed -$366 – 3820
2024
Q3 		$366 Sell
88
-13
-13% -$68 ﹤0.01% 3436
2024
Q2 		$551 Sell
101
-82
-45% -$653 ﹤0.01% 3196
2024
Q1 		$1.83K Buy
183
+95
+108% +$712 ﹤0.01% 2772
2023
Q4 		$483 Buy
+88
New +$324 ﹤0.01% 2973

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

GAMMA Investing's SANA Position: Q2 2026 in Review

GAMMA Investing sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 222 shares — an estimated $639 sold.

GAMMA Investing first reported a position in SANA in Q4 2023 and held it in 6 quarters. The position peaked at $1.83K in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • GAMMA Investing reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
  • GAMMA Investing sold 222 Sana Biotechnology shares in Q2 2026, an estimated $639.
  • GAMMA Investing first reported a position in Sana Biotechnology in Q4 2023 and held it in 6 quarters.
  • GAMMA Investing's Sana Biotechnology position peaked at $1.83K in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.